Clinical trial

Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema

NCT00367133 · Jaeb Center for Health Research, Other · Completed

Key facts

NCT number NCT00367133
Title Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
Official title A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema
Acronym IVT
Lead sponsor Jaeb Center for Health Research, Other
Collaborators National Eye Institute (NEI) NIH Allergan Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diabetic Macular Edema
Intervention type Drug, Procedure
Interventions Standard of Care Group, 1mg triamcinolone acetonide, 4mg triamcinolone acetonide
Enrollment 840
Start date Jul 1, 2004
Primary completion May 1, 2008
Completion Oct 1, 2008
First posted Aug 22, 2006
Last update posted Aug 26, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies